Inhibition of tau-tau association

Details Inhibition of tau-tau association Inhibition of tau-tau association

2005-10-11

2005-10-11

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

06953794

ABSTRACT:
A composition and use thereof for the prophylaxis or treatment of Alzheimer's disease, motor neurone disease, Lewy body disease, Pick's disease or progressive supranuclear palsy. The composition includes an agent which modulates or inhibits tau-tau association and which does not inhibit tau-tubulin binding. In the method the agent is administered to an individual in order to achieve the desired therapeutic effect. Preferably the agent which is administered is a phenothiazine compound.

REFERENCES:
patent: 5827644 (1998-10-01), Floyd et al.
patent: A-4430091 (1996-02-01), None
patent: 0 457 295 (1991-11-01), None
patent: 0 457 295 (1991-11-01), None
patent: WO-A-9303177 (1993-02-01), None
patent: WO-A-9303369 (1993-02-01), None
patent: 9311231 (1993-06-01), None
patent: WO-A-9311231 (1993-06-01), None
patent: WO-A-9505466 (1995-02-01), None
patent: WO-A-9604915 (1996-02-01), None
R. Lai, The Role of Abnormal Phosphorylation of Tau Protein in the Development of Neurofibrillary Pathology in Alzheimer's Disease, pp. 1-243.
Dissertation by Claude Wischik, p. 182, 189, 233 and 234, No date available.
C. Wischik, “Molecular Neuropathology of Alzheimer's Disease” (1989), pp. 44-70.
Garcini et al.,Biochemical and Biophysical Research Communications,Self Assembly of Microtubule Associated Protein TAU into Filaments Resembling those found in Alzheimer Disease (1986), pp. 790-797.
Garcini et al.,J. Biochem.102, No. 6, “In Vitro Conditions for the Self-Polymerization of the Microtubule-Associated Protein, Tau Factor” (1987), pp. 1415-1421.
Garcini et al.,Elsevier Science Publishers B.V.,“Tau Factor Polymers are Similar to Paired Helical Filaments of Alzheimer's Disease” (1988), pp. 150-154.
Ksiezak-Reding and Yen,Neuron,vol. 6, pp. 717-728, Structural Stability of Paired Helical Filaments Requires Microtubule Binding Domains of Tau: A Model for Self-Association (1991).
Wille et al.,J. Cell Biol.,118 (1992) 573-584, Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro.
Lee et al., untitled,Science,vol. 251 (1992).
Kziezak-Reding and Wall,Neurobiology of Aging,vol. 15, No. 1, pp. 11-18. “Mass and Physical Dimensions of Two Distinct Populations of Paired Helical Filaments” (1993).
Wischik et al.,Proc. Natl. Acad. Sci. USA,vol. 85, pp. 4506-4510 (1988) “Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease”.
Wischik et al.,Proc. Natl. Acad. Sci. USA,vol. 85, pp. 4884-4888, “Structural characterization of the core of the paired helical filament of Alzheimer disease” (1988).
Wischik et al.,Proc. Natl. Acad. Sci. USA,vol. 93, pp. 11213-11218 (1996) “Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines”.
Ksiezak-Reding, Assembled tau filaments differ from native paired helical filaments as determiend by scanning transmission electron microscopy (STEM) (1998), pp. 86-98.
Mena et al.,Journal of Neuropathology and Experimental Neurology,“A Progressive Depsotion of Paired Helical Filaments (PHF) in the Brain Characterizes the Evolution of Dementia in Alzheimer's Disease” (1991), pp. 474-490.
Mena et al.,Acta Neuropathol.,Monitoring Pathological Assembly of tau and β-Amyloid Proteins in Alzheimer's Disease (1994), pp. 50-56.
Mena et al.,Acta Neuropathol,“Staging the Pathological Assembly of Truncated tau Protein into Paired Helical Filaments in Alzheimer's Disease” (1995), pp. 633-641.
C.M. Wischik et al. “Quantitative Analysis of Tau Protein in Paried Helical Filament Preparations: Implications for the Role of Tau Protein Phosphorylation in PHF Assembly in Alzheimer's Disease”,Neurobiology of Aging,vol. 16, No. 3, pp. 409-431, 1995.
C.M. Wischik et al., “Author's Response to Commentaries”, pp. 423-431, No date available.
C.M. Wischik et al., “Structure, Biochemistry and Molecular Pathogenesis of Paired Helical Filaments in Alzheimer's Disease”,Pathobiology of Alzheimer's Disease, pp. 10-39, 1995.
V.M.-Y. Lee et al., “A68: A Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau”,Science,vol. 251, pp. 675-678, No date available.
M. Goedert et al., “Tau Proteins of Alzheimer Paired Helical Filaments: Abnormal Phosphorylation of All Six Brain Isoforms”,Neuron,vol. 8, pp. 159-168, Jan. 1992.
C.M. Wischik et al., “Structural Characterization of the Core of the Paired Helical Filament of Alzheimer's Disease”,Proc. Natl. Acad. Sci. USA,vol. 85, pp. 4884-4888, Jul. 1998.
C.M. Wischik et al., “Isolation of a Fragment of Tau Derived From the Core of the Paired Helical Filament of Alzheimer's Disease”,Proc. Natl. Acad. Sci. USA,vol. 85, pp. 4506-4510, Jun. 1998.
R. Jakes et al., “Identification of 3- and 4-repeat Tau Isoforms Within The PHF in Alzheimer's Disease”,The EMBO Journal,vol. 10, No. 10, pp. 2725-2729, 1991.
M. Novak et al., “Molecular Characterization of the Minimal Protease Resistant Tau Unit of the Alzheimer's Disease Paired Helical Filament”,The EMBO Journal, vol. 12, No. 1, pp. 365-370, 1993.
S.-H. Yen et al., “Alzheimer's Neurofibrillary Tangles Contain Unique Epitopes and Epitopes in Common With the Heat-Stable Microtubule Associated Proteins Tau and MAP2”,AJP,vol. 126, Jan. 1987.
J.P. Brion et al., “Characterization of a Partial cDNA Specific for the High Molecular Weight Microtubule-Associated Protein MAP2 That Encodes Epitopes Shared with Paired Helical Filaments of Alzheimer's Disease”,Dementia,1990:1:304-315.
M.W. Klymkowsky, “Weaving a Tangled Web: the Interconnected Cytoskeleton”,Nature Cell Biology,vol. 1, No. 5, p. E121 (1999).
R. Brandt, “Cytoskeletal Mechanisms of Axon Outgrowth and Pathfinding”,Cell Tissue Res.,(1998) 292:181-189.
D. van Rossum et al., “Cytoskeletal Dynamics in Dendritic Spines: Direct Modulation By Glutamate Receptors?”,Trends Neurosci,(1992) 22, 290-295.
R. Sato-Harada et al., “Microtubule-associated Proteins Regulate Microtubule Function as the Track for Intracellular Membrane Organelle Transports”,Cell Structure and Function,21:283-295 (1996).
A. Grover et al., “5′ Splice Site Mutations in Tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10*”,The Journal of Biological Chemistry,vol. 274, No. 21, May 21 Issue, pp. 15134-15143, 1999.
M. Hutton et al., “Association of Missense of 5′-splice-site Mutations in Tau With the Inherited Dementia FTDP-17”,Nature,vol. 393, pp. 702-705, Jun. 18, 1998.
T. Ishihara et al., “Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform”,Neuron,vol. 24, pp. 751-762, Nov. 1999.
A. Harada et al., “Altered Microtubule Organization In Small-Calibre Axons of Mice Lacking Tau Protein”,Letters to Nature,No date available.
I. Tint et al., “Acute Inactivation of Tau Has No Effect on Dynamics of Microtubules in Growing Axons of Cultured Sympathetic Neurons”,The Journal of Neuroscience,Nov. 1, 1998, 18(21):8661-8673.
S. Kaech et al., “Cytoskeletal Plasticity in Cells Expressing Neuronal Microtubule-Associated Proteins”,Neuron,vol. 17, 1189-1199, Dec. 1996.
R. Y. K. Lai et al., “Examination of Phosphorylated Tau Protein as a PHF-Precursor at Early State Alzheimer's Disease”,Neurobiology of Aging,vol. 16, No. 3, pp. 433-445, 1995.
E. Braak et al., “Alzheimer's Disease: Transiently Developing Dendritic Changes in Pyramidal Cells of Sector CA1 of the Ammon's Horn”,Acta Neuropathol.,(1997) 93:323-325.
B. H. Anderton et al., “Dentritic Changes in Alzheimer's Disease and Factors That May Underlie These Changes”,Prog. Neurobiol.,Aug. 1998; 55(6):595-609.
C. Smith et al., “

Affiliated with

Also associated with

Rating

Inhibition of tau-tau association does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of tau-tau association, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of tau-tau association will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3441297